Related references
Note: Only part of the references are listed.Novel In Vitro-In Vivo Extrapolation (IVIVE) Method to Predict Hepatic Organ Clearance in Rat
Ken-ichi Umehara et al.
PHARMACEUTICAL RESEARCH (2012)
Prediction of the Intestinal First-pass Metabolism of CYP3A and UGT Substrates in Humans from in vitro Data
Haruka Nishimuta et al.
DRUG METABOLISM AND PHARMACOKINETICS (2011)
Evaluation of Pharmacokinetic Interactions Between Amlodipine, Valsartan, and Hydrochlorothiazide in Patients With Hypertension
Prafulla Bhad et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
PhRMA CPCDC Initiative on Predictive Models of Human Pharmacokinetics, Part 3: Comparative Assessement of Prediction Methods of Human Clearance
Barbara J. Ring et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Quantitative Prediction of Intestinal Metabolism in Humans from a Simplified Intestinal Availability Model and Empirical Scaling Factor
Keitaro Kadono et al.
DRUG METABOLISM AND DISPOSITION (2010)
Prediction of Human Intestinal First-Pass Metabolism of 25 CYP3A Substrates from In Vitro Clearance and Permeability Data
Michael Gertz et al.
DRUG METABOLISM AND DISPOSITION (2010)
Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity
Brandon Swift et al.
DRUG METABOLISM REVIEWS (2010)
Application of physiologically based pharmacokinetic modeling and clearance concept to drugs showing transporter-mediated distribution and clearance in humans
Takao Watanabe et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism
Yi-Jing He et al.
CLINICA CHIMICA ACTA (2009)
In vitro-in vivo Extrapolation of Transporter-mediated Clearance in the Liver and Kidney
Hiroyuki Kusuhara et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption
Joseph M. Custodio et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Pharmacokinetics of the Oral Direct Renin Inhibitor Aliskiren in Combination With Digoxin, Atorvastatin, and Ketoconazole in Healthy Subjects: The Role of P-Glycoprotein in the Disposition of Aliskiren
Sujata Vaidyanathan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Challenges and opportunities with modelling and simulation in drug discovery and drug development
T. Lave et al.
XENOBIOTICA (2007)
Inhibition constants, inhibitor concentrations and the prediction of inhibitory drug drug interactions: Pitfalls, progress and promise
KA Bachmann
CURRENT DRUG METABOLISM (2006)
Predicting drug disposition via application of BCS: Transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system
CY Wu et al.
PHARMACEUTICAL RESEARCH (2005)
Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes
K Ito et al.
PHARMACEUTICAL RESEARCH (2004)
Drug metabolism and drug interactions:: Application and clinical value of in vitro models
K Venkatakrishnan et al.
CURRENT DRUG METABOLISM (2003)
Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin
AL Mazzu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Share Paper
